Battle Royale: Pacific Biosciences of California vs. Athena Health

Listen to the Battle Royale, a regular feature in our Supernova premium service where Fool co-founder David Gardner pits two stocks against each other. Which one will emerge victorious?

We're giving you a free sneak peek into this segment that was taped in April 2012.

For more stock ideas, check out our free report "3 Stocks That Will Help You Retire Rich," in which we name stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of.

Max Keeler: Okay, our next pairing is Pacific Biosciences (NASDAQ: PACB  ) of California vs. Athena Health (NASDAQ: ATHN  ) .

David Gardner: So between Pac Bio and Athena Health, that's a pretty easy one for me. I think that Athena Health is a healthier company with healthier prospects. It isn't hard to say that when we reflect that Pacific Bio Sciences , which I recommended along with my friend, Karl Thiel, I think a year ago, and that same issue, April 2011, NXP (NASDAQ: NXPI  ) , and Pac Bio came out, and Pac Bio was at fourteen and a half then; it's at about three bucks now, below three.

Max: Mmm.

David Gardner: So it has performed badly as a stock. And I think there are many more questions about Pacific Bio's business than, what was the competitor?

Max: Athena Health.

David Gardner: Athena Health, right. I just think Athena Health is a surer bet. Nothing is a sure bet on the market, but between those two it's easy for me to push Athena H. forward.

Max: Okay.


Read/Post Comments (0) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2256467, ~/Articles/ArticleHandler.aspx, 4/19/2014 12:55:39 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement